Purple Book

The Purple Book is a publicly avAIlable online Database maintained by the U.S. Food and Drug Administration (FDA). It serves as a reference for licensed biological products, including Information about patents and exclusivity. While it is not an AI product in the conventional sense, it functions as a specialized research tool that can be used within Workflows related to drug development and regulatory affairs.

What it does

The Purple Book allows users to search for biological products licensed by the FDA. It provIDEs details such as the product name, license number, and date of licensure, as well as infORMation on patents and exclusivity periods. Users can perform advanced searches by various criteria to find specific products or compare data across multiple entries.

Key capabilities

• Advanced search: Filter by product name, license number, date, and other attributes.
• Patent and exclusivity data: View patent numbers, expiration dates, and exclusivity codes.
• Product details: Access information about the manufACTurer, product type, and APProval pathway.
• Export options: Results can typically be exported for further analysis.

Who it is for

The tool is primarily used by regulatory Professionals, pharmaceutical researchers, legal teams, and others involved in biologics development or Intellectual pRoPErty analysis. It supports tasks such as competitive intelligence, patent landscape analysis, and regulatory submission preparation. It is not intended for direct patient care or CLInical decision-making.

How to get started

Users can access the Purple Book through the FDA website. No registration is required. The interface offers simple and advanced search options. Help documentation and tutorials may be available on the site to guide new users. It is adVisable to review the data fields and search tips to make the most of the tool.

Pricing and access caveat

The Purple Book is freely accessible to the public. There are no subscription fees or paid tiers. However, users should note that the information is provided as-is by the FDA, and while it is regularly updated, it may not always reflect the most current developments. The database is intended for informational purposes and should not be considered legal or regulatory advice. Access may be subject to the FDA's website terms of use.